NCT03631355View on ClinicalTrials.gov

Reducing Hemarthrosis in ACL Reconstruction With BTB Autograft by the Administration of Intravenous TXA

PHASE4CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

June 6, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions

Anterior Cruciate Ligament Reconstruction

Interventions

DRUG

Tranexamic Acid

One gram of intravenous tranexamic acid will be administered before tourniquet inflation and 1 gram of IV TXA before closure of the incision.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER

NCT03631355 - Reducing Hemarthrosis in ACL Reconstruction With BTB Autograft by the Administration of Intravenous TXA | Biotech Hunter | Biotech Hunter